Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Carmen S. Horjus Talabur Horje"'
Autor:
Lisanne Lutter, Britt Roosenboom, Eelco C. Brand, José J. ter Linde, Bas Oldenburg, Ellen G. van Lochem, Carmen S. Horjus Talabur Horje, Femke van Wijk
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 5, Pp 1567-1581 (2021)
Background & Aims: Tissue-resident memory T (Trm) cells, both of the CD4 and CD8 lineage, have been implicated in disease flares in inflammatory bowel disease. However, data are conflicting regarding the profile of human CD8+ Trm cells, with studies
Externí odkaz:
https://doaj.org/article/a4509fd606384f5597875baba536cee4
Autor:
Britt Roosenboom, Ellen G. van Lochem, Jos Meijer, Carolijn Smids, Stefan Nierkens, Eelco C. Brand, Liselot W. van Erp, Larissa G.J.M. Kemperman, Marcel J.M. Groenen, Carmen S. Horjus Talabur Horje, Peter J. Wahab
Publikováno v:
Cells, Vol 9, Iss 4, p 891 (2020)
PNAd and MAdCAM-1 addressins on venules are of importance in T-cell homing and potential therapeutic targets in ulcerative colitis (UC). Normally, PNAd+ high endothelial venules (HEVs) are only present in lymphoid organs, whereas small numbers of MAd
Externí odkaz:
https://doaj.org/article/7ef6bd7a388d4bd392862fca0b51b394
Autor:
Monique Boekema, Carmen S. Horjus – Talabur Horje, Britt Roosenboom, Lian Roovers, Matthijs van Luin
Publikováno v:
British Journal of Clinical Pharmacology. 88:3741-3748
The effect of the Dutch nationwide adjustment of reducing 6-thioguanine nucleotide (6-TGN) target values (from 600-1200 to 320-630 pmol/8 × 10This retrospective study was performed in inflammatory bowel disease patients treated with azathioprine or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5066e98714e4c20a69d33886c0dcb651
https://doi.org/10.1111/bcp.15315
https://doi.org/10.1111/bcp.15315
Autor:
Remi Mahmoud, Edo H.J. Savelkoul, Wout Mares, Rogier Goetgebuer, Ben J.M. Witteman, Daan B. de Koning, Sebastiaan A.C. van Tuyl, Itta Minderhoud, Maurice W.M. D. Lutgens, Dilek Akol-Simsek, Fiona D.M. van Schaik, Herma H. Fidder, Jeroen M. Jansen, Petra G.A. van Boeckel, Nofel Mahmmod, Carmen S. Horjus-Talabur Horje, Tessa E.H. Römkens, Jean-Frédéric Colombel, Frank Hoentjen, Bindia Jharap, Bas Oldenburg
Publikováno v:
Clinical Gastroenterology and Hepatology, 21, 3, pp. 750-760.e4
Clinical Gastroenterology and Hepatology, 21(3), 750-760.e4. W.B. Saunders
Clinical Gastroenterology and Hepatology, 21, 750-760.e4
Clinical Gastroenterology and Hepatology, 21(3), 750-760.e4. W.B. Saunders
Clinical Gastroenterology and Hepatology, 21, 750-760.e4
Contains fulltext : 291394.pdf (Publisher’s version ) (Open Access) BACKGROUND & AIMS: Discontinuation of anti-tumor necrosis factor-α treatment (anti-TNF) (infliximab and adalimumab) in patients with inflammatory bowel disease (IBD) is associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba6229d4e93f40aa5dba971b240530c
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/291394
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/291394
Autor:
Jose J. ter Linde, Eelco C. Brand, Carmen S Horjus Talabur Horje, Bas Oldenburg, Britt Roosenboom, Lisanne Lutter, Ellen G van Lochem, Femke van Wijk
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 5, Pp 1567-1581 (2021)
Background & Aims Tissue-resident memory T (Trm) cells, both of the CD4 and CD8 lineage, have been implicated in disease flares in inflammatory bowel disease. However, data are conflicting regarding the profile of human CD8+ Trm cells, with studies s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1f194dcf2e94e90faa90b1c684b680c
https://doi.org/10.1016/j.jcmgh.2021.06.022
https://doi.org/10.1016/j.jcmgh.2021.06.022
Autor:
Peter J. Wahab, Marcel J M Groenen, Prashant Komdeur, Robert van Cingel, Carmen S Horjus Talabur Horje, Wendy Dijkstra-Heida, Liselot W van Erp, Camilo S Liem, Britt Roosenboom, J. Wisse
Publikováno v:
Digestive Diseases and Sciences. 66:597-604
Fatigue significantly impacts the quality of life of patients with inflammatory bowel disease (IBD). This study aimed to assess the effect of a personalized, intensive exercise program on fatigue, health-related quality of life (HRQoL), and cardiores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::210d1fa9dfee317a71898619dc5ff28d
https://doi.org/10.1007/s10620-020-06222-5
https://doi.org/10.1007/s10620-020-06222-5
Autor:
Maarten te Groen, Monica E. Derks, Charlotte P. Peters, Gerard Dijkstra, Annemarie C. De Vries, Tessa Romkens, Carmen S. Horjus Talabur Horje, Nanne De Boer, Michiel E. De Jong, Iris D. Nagtegaal, Lauranne Derikx, Frank Hoentjen
Publikováno v:
Gastrointestinal Endoscopy. 95:AB110-AB111
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e14ff265372d4a34c56258dfecb38413
https://doi.org/10.1016/j.gie.2022.04.282
https://doi.org/10.1016/j.gie.2022.04.282
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 54(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d155c4c13bc207f6b8312c64e687467
https://pubmed.ncbi.nlm.nih.gov/34331801
https://pubmed.ncbi.nlm.nih.gov/34331801
Autor:
Marcel J M Groenen, Jan Willem Leeuwis, Ellen G van Lochem, Carolijn Smids, Peter J. Wahab, Elly van Koolwijk, Britt Roosenboom, Carmen S Horjus Talabur Horje
Publikováno v:
Scandinavian journal of gastroenterology. 56(6)
Immunotherapy, targeting programmed death-1 (PD-1) enhances antitumor T-cell activity in patients with malignancies. Blocking PD-1 or its ligand may lead to fulminant colitis as serious adverse event in these patients. Since little is known of the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d7d971ee7490dffa5e8b5f7039cd722
https://pubmed.ncbi.nlm.nih.gov/33779456
https://pubmed.ncbi.nlm.nih.gov/33779456
Autor:
Eelco C. Brand, Marjolein A.Y. Klaassen, Ranko Gacesa, Arnau Vich Vila, Hiren Ghosh, Marcel R. de Zoete, Dorret I. Boomsma, Frank Hoentjen, Carmen S. Horjus Talabur Horje, Paul C. van de Meeberg, Gonneke Willemsen, Jingyuan Fu, Cisca Wijmenga, Femke van Wijk, Alexandra Zhernakova, Bas Oldenburg, Rinse K. Weersma, Pieter Honkoop, Rutger J. Jacobs, Cyriel Y. Ponsioen, Nanne K.H. de Boer, Yasser A. Alderlieste, Margot A. van Herwaarden, Sebastiaan A.C. van Tuyl, Maurice W. Lutgens, C. Janneke van der Woude, Wout G.M. Mares, Daan B. de Koning, Joukje H. Bosman, Juda Vecht, Anneke M.P. de Schryver, Andrea E. van der Meulen-de Jong, Marieke J. Pierik, Paul J. Boekema, Robert J. Verburg, Bindia Jharap, Jeroen M. Jansen, Pieter C.F. Stokkers, Rutger Quispel, Nofel Mahmmod, Rachel L. West, Marleen Willems, Itta M. Minderhoud, Herma H. Fidder, Fiona D.M. van Schaik, Meike M.C. Hirdes, Nynke A. Boontje, Bart L.M. Müskens, Marielle J.L. Romberg-Camps
Publikováno v:
Gastroenterology, 160(6), 1970-1985. W B SAUNDERS CO-ELSEVIER INC
Gastroenterology, 160(6), 1970-1985. W.B. Saunders Ltd
Brand, E C, Boomsma, D I, Willemsen, G, Weersma, R K, Romberg-Camps, M J L & Dutch TWIN-IBD consortium and the Dutch Initiative on Crohn and Colitis 2021, ' Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients ', Gastroenterology, vol. 160, no. 6, pp. 1970-1985 . https://doi.org/10.1053/j.gastro.2021.01.030
Gastroenterology, 160, 1970-1985
Gastroenterology, 160, 6, pp. 1970-1985
Gastroenterology, 160(6), 1970-1985. W.B. Saunders Ltd
Brand, E C, Boomsma, D I, Willemsen, G, Weersma, R K, Romberg-Camps, M J L & Dutch TWIN-IBD consortium and the Dutch Initiative on Crohn and Colitis 2021, ' Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients ', Gastroenterology, vol. 160, no. 6, pp. 1970-1985 . https://doi.org/10.1053/j.gastro.2021.01.030
Gastroenterology, 160, 1970-1985
Gastroenterology, 160, 6, pp. 1970-1985
Background & aims: It is currently unclear whether reported changes in the gut microbiome are cause or consequence of inflammatory bowel disease (IBD). Therefore, we studied the gut microbiome of IBD-discordant and -concordant twin pairs, which offer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb00ab5f8cc85e5e85837426a67526e7
https://doi.org/10.1053/j.gastro.2021.01.030
https://doi.org/10.1053/j.gastro.2021.01.030